Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Carl I. Shaia"'
Autor:
Julia R. Port, Jade C. Riopelle, Sarah van Tol, Arthur Wickenhagen, Eric Bohrnsen, Daniel E. Sturdevant, Rebecca Rosenke, Jamie Lovaglio, Justin Lack, Sarah L. Anzick, Kathleen Cordova, Kwe Claude Yinda, Patrick W. Hanley, Tony Schountz, Lon V. Kendall, Carl I. Shaia, Greg Saturday, Craig Martens, Benjamin Schwarz, Vincent J. Munster
Publikováno v:
npj Viruses, Vol 2, Iss 1, Pp 1-15 (2024)
Abstract The ancestral sarbecovirus giving rise to SARS-CoV-2 is posited to have originated in bats. While SARS-CoV-2 causes asymptomatic to severe respiratory disease in humans, little is known about the biology, virus tropism, and immunity of SARS-
Externí odkaz:
https://doaj.org/article/04082be39d684a2987f4130c09c16462
Autor:
Carrie M. Long, Paul A. Beare, Diane C. Cockrell, Jonathan Fintzi, Mahelat Tesfamariam, Carl I. Shaia, Robert A. Heinzen
Publikováno v:
npj Vaccines, Vol 6, Iss 1, Pp 1-14 (2021)
Abstract Coxiella burnetii is the bacterial causative agent of the zoonosis Q fever. The current human Q fever vaccine, Q-VAX®, is a fixed, whole cell vaccine (WCV) licensed solely for use in Australia. C. burnetii WCV administration is associated w
Externí odkaz:
https://doaj.org/article/d0529c4e3ca2440ab6147266ba854488
Autor:
Kathleen A. Cashman, Eric R. Wilkinson, Carl I. Shaia, Paul R. Facemire, Todd M. Bell, Jeremy J. Bearss, Joshua D. Shamblin, Suzanne E. Wollen, Kate E. Broderick, Niranjan Y. Sardesai, Connie S. Schmaljohn
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 13, Iss 12, Pp 2902-2911 (2017)
Lassa virus (LASV) is an ambisense RNA virus in the Arenaviridae family and is the etiological agent of Lassa fever, a severe hemorrhagic disease endemic to West and Central Africa. There are no US Food and Drug Administration (FDA)-licensed vaccines
Externí odkaz:
https://doaj.org/article/75384ca5e7c34c10b50ed4e553af59e1
Autor:
Isaac L. Downs, Carl I. Shaia, Xiankun Zeng, Joshua C. Johnson, Lisa Hensley, David L. Saunders, Franco Rossi, Kathleen A. Cashman, Heather L. Esham, Melissa K. Gregory, William D. Pratt, John C. Trefry, Kyle A. Everson, Charles B. Larcom, Arthur C. Okwesili, Anthony P. Cardile, Anna Honko
Publikováno v:
Viruses, Vol 12, Iss 6, p 593 (2020)
Lassa virus (LASV), an arenavirus causing Lassa fever, is endemic to West Africa with up to 300,000 cases and between 5000 and 10,000 deaths per year. Rarely seen in the United States, Lassa virus is a CDC category A biological agent inasmuch deliber
Externí odkaz:
https://doaj.org/article/d1ff1ce80e4b46f38710d04a676990a9
Autor:
Kathleen A. Cashman, Eric R. Wilkinson, Xiankun Zeng, Anthony P. Cardile, Paul R. Facemire, Todd M. Bell, Jeremy J. Bearss, Carl I. Shaia, Connie S. Schmaljohn
Publikováno v:
mBio, Vol 9, Iss 5 (2018)
ABSTRACT Lassa virus (LASV) causes a severe, often fatal hemorrhagic disease in regions in Africa where the disease is endemic, and approximately 30% of patients develop sudden-onset sensorineural hearing loss after recovering from acute disease. The
Externí odkaz:
https://doaj.org/article/ae9350fbdf8e4ad6afc4472d4595d22d
Autor:
Niranjan Y. Sardesai, Connie S. Schmaljohn, Catherine V. Badger, Mary C. Guttieri, Kristin W. Spik, Carl I. Shaia, Amy C. Shurtleff, Todd M. Bell, Kate E. Broderick, Eric R. Wilkinson, Kathleen A. Cashman
Publikováno v:
Vaccines, Vol 1, Iss 3, Pp 262-277 (2013)
Lassa virus (LASV) causes a severe, often fatal, hemorrhagic fever endemic to West Africa. Presently, there are no FDA-licensed medical countermeasures for this disease. In a pilot study, we constructed a DNA vaccine (pLASV-GPC) that expressed the LA
Externí odkaz:
https://doaj.org/article/6e4012d0d77e430c978814f7afffcb6c
Autor:
Julia R. Port, Dylan H. Morris, Jade C. Riopelle, Claude Kwe Yinda, Victoria A. Avanzato, Myndi G. Holbrook, Trenton Bushmaker, Jonathan E. Schulz, Taylor A. Saturday, Kent Barbian, Colin A. Russell, Rose Perry-Gottschalk, Carl I. Shaia, Craig Martens, James O. Lloyd-Smith, Robert J. Fischer, Vincent J. Munster
Publikováno v:
bioRxiv : the preprint server for biology.
Airborne transmission is one of the major routes contributing to the spread of SARS-CoV-2. Successful aerosol transmission occurs when people release respiratory particles carrying infectious virus in the fine aerosol size range. It remains poorly un
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ae93a80f7450a65d05491e01758baa4
https://pubmed.ncbi.nlm.nih.gov/36032963
https://pubmed.ncbi.nlm.nih.gov/36032963
Autor:
Julia R. Port, Claude Kwe Yinda, Jade C. Riopelle, Zachary A. Weishampel, Taylor A. Saturday, Victoria A. Avanzato, Jonathan E. Schulz, Myndi G. Holbrook, Kent Barbian, Rose Perry-Gottschalk, Elaine Haddock, Craig Martens, Carl. I. Shaia, Teresa Lambe, Sarah C. Gilbert, Neeltje van Doremalen, Vincent J. Munster
Publikováno v:
bioRxiv : the preprint server for biology.
Omicron has demonstrated a competitive advantage over Delta in vaccinated people. To understand this, we designed a transmission chain experiment using naïve, intranasally (IN) or intramuscularly (IM) vaccinated, and previously infected (PI) hamster
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b000fa45a8fbc82b65f9a05e353a276
https://pubmed.ncbi.nlm.nih.gov/35982658
https://pubmed.ncbi.nlm.nih.gov/35982658
Autor:
William D. Pratt, Melissa Gregory, Kathleen A. Cashman, Arthur C Okwesili, Isaac L Downs, Xiankun Zeng, John Trefry, Anthony P. Cardile, Heather L. Esham, Kyle A Everson, Carl I. Shaia, Lisa E. Hensley, Anna N. Honko, David L. Saunders, Charles B Larcom, Franco Rossi, Joshua C. Johnson
Publikováno v:
Viruses
Volume 12
Issue 6
Viruses, Vol 12, Iss 593, p 593 (2020)
Volume 12
Issue 6
Viruses, Vol 12, Iss 593, p 593 (2020)
Lassa virus (LASV), an arenavirus causing Lassa fever, is endemic to West Africa with up to 300,000 cases and between 5000 and 10,000 deaths per year. Rarely seen in the United States, Lassa virus is a CDC category A biological agent inasmuch deliber
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b270c5cec324028931c2d2d367c388df
Autor:
Suzanne E. Wollen, Paul R Facemire, Kathleen A. Cashman, Niranjan Y. Sardesai, Carl I Shaia, Kate E. Broderick, Connie S. Schmaljohn, Todd M. Bell, Joshua D. Shamblin, Jeremy J. Bearss, Eric R. Wilkinson
Publikováno v:
Human Vaccines & Immunotherapeutics
Lassa virus (LASV) is an ambisense RNA virus in the Arenaviridae family and is the etiological agent of Lassa fever, a severe hemorrhagic disease endemic to West and Central Africa.1,2 There are no US Food and Drug Administration (FDA)-licensed vacci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcd6401980588cfbcc7b118a5093c20d
http://europepmc.org/articles/PMC5718832
http://europepmc.org/articles/PMC5718832